Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-02-06 @ 6:57 PM
Study NCT ID:
NCT01689220
Status:
COMPLETED
Last Update Posted:
2014-09-04
First Post:
2012-09-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea
Sponsor:
Solasia Pharma K.K.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SP-02L03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |